Bullous pemphigoid (BP) is an autoimmune disease associated with autoantibodies directed against the hemidesmosomal antigens anti-BP230 and anti-B180. Neonatal mice injected with rabbit antimouse BP180 IgG develop a BP-like disease. Complement, immune complexes, mast cells, and neutrophils play a key role in subepidermal blistering in this animal model. In this study we investigated the role of β2 integrins in experimental BP. Wild-type (WT) mice pretreated with neutralizing antibody against CD11a (LFA-1), CD11b (Mac-1), CD11a plus CD11b, or CD18 alone failed to develop BP when injected with pathogenic anti-mBP180 IgG. This was associated with a significant reduction in neutrophil accumulation in neutralizing antibody treated mice. Mac-1-deficient (Mac-1 KO) mice were resistant to experimental BP despite normal complement deposition and mast cell and neutrophil degranulation. Neutrophil infiltration in Mac-1 KO mice was severely impaired at 24 h. However, more neutrophils accumulated in the skin of Mac-1 KO mice compared to WT mice at early time points (2-4 h), which was associated with an increase in their survival as determined by apoptosis markers. These data suggest that β2 integrins play differential roles in experimental BP: LFA-1 is required for neutrophil recruitment while Mac-1 mediates late neutrophil accumulation and apoptosis of infiltrating neutrophils.
INTRODUCTION
Bullous pemphigoid (BP) is a subepidermal blistering skin disorder of the elderly. 1 Lesional skin of BP patients is characterized by a detachment of the basal keratinocytes of the epidermis from the dermis resulting in tense, fluid filled vesicles. Immunofluorescence (IF) studies demonstrated that these patients exhibit circulating and tissue-bound autoantibodies directed against antigens of the basement membrane zone (BMZ). [2] [3] [4] [5] [6] [7] BP autoantibodies recognize two antigens, BP230 and BP180, which are localized in the hemidesmosome, the main epidermal structure involved in dermal-epidermal adhesion. [5] [6] [7] [8] [9] [10] [11] [12] [13] The BP230 antigen is restricted to the cytoplasmic plaque of the hemidesmosome and appears to interact directly with the intermediate filament network. 8, 9 The BP180 antigen is a type II transmembrane protein that spans the lamina lucida, projecting into the lamina densa of the basement membrane.
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The ectodomain of human BP180 harbors major extracellular antigenic sites recognized by sera from BP patients. 17, 18 Administration of rabbit antibody to mBP180 in neonatal mice results in the binding of pathogenic antibody to its target on basal keratinocytes resulting in neutrophil accumulation, complement deposition at the BMZ junction and subepidermal blistering reminiscent of human BP lesions. [19] [20] [21] [22] [23] [24] [25] The early phase of neutrophil infiltration is dependent on complement activation leading to mast cell degranulation. 20, 21 Upon the initial neutrophil mediated tissue injury skin inflammation is amplified by the recruitment of additional neutrophils resulting in clinical blistering. 25 This later (amplification) stage of neutrophil infiltration is mediated through local tissue damage of the basement membrane by released neutrophil elastase (NE) and MMP-9 by activated neutrophils. [23] [24] [25] It is noteworthy that a threshold of neutrophil accumulation is required for clinical blistering with only a 30% reduction in neutrophil influx resulting in the inhibition of subepidermal blisters. 21 Thus the tissue burden of infiltrating neutrophils and their cytotoxic products are key predictors of disease progression in this model.
Neutrophil accumulation in tissues is a balance of neutrophil recruitment and neutrophil clearance. Recruitment of inflammatory cells requires firm integrin-mediated adhesion and diapedesis. 26, 27 The ß2-integrin family members LFA-1 (CD11a/CD18), Mac-1 (CD11b/CD18), and p150,95 (CD11c/CD18) are expressed on neutrophils and have diverse functions, including leukocyte recruitment to sites of inflammation, host defense, and immune-mediated tissue injury. 28, 29 Neutrophil clearance occurs upon neutrophil apoptosis followed by engulfment of the apoptotic cells via tissue macrophages. A deficiency in Mac-1 alone results in increased neutrophil accumulation at inflamed sites that is associated with enhanced survival of extravasated neutrophils. 30 Finally, Mac-1, also known as complement receptor 3 (CR3) is a major receptor for complement C3bi and its interaction with this ligand may be important for promoting neutrophil cytotoxic functions. 31 In this study, we investigated the role of β2 integrins and their relative contributions to neutrophil accumulation and disease development in experimental BP.
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MATERIALS AND METHODS

Laboratory animals:
Breeding pairs of wild-type C57BL/6J (WT) mice were purchased from Jackson Laboratories. C57BL/6J Mac-1-deficient (Mac-1 KO) mice were generated using standard gene-targeting approaches using a targeting vector in which the 64bp exon encoding the translational initiation codon was replaced with a 1.7kb neomycin gene cassette driven by a PGK promoter. Homozygous animals were shown to be negative for Mac-1 expression on peripheral blood neutrophils and peritoneal macrophages thus confirming knock-down of Mac-1 protein levels in these animals. 30 The mice were maintained at the University of North Carolina-Chapel
Hill Animal Center. Neonatal mice (24-36 h old with body weights between 1.4 and 1.6 g) were used for passive transfer experiments. Animal care and animal experiments were in accordance with the Animal Care Committee at the University of North Carolina at Chapel Hill and NIH guidelines.
Preparation of pathogenic anti-BP180 IgG:
The preparation of recombinant murine BP180 and the immunization of rabbits were performed as previously described. 19 Briefly, a segment of the ectodomain of the murine BP180 antigen was expressed as a glutathione S-transferase (GST) fusion protein using the pGEX prokaryotic expression system (Pharmacia LKB Biotechnology). 32 The murine BP180 fusion protein, designated GST-mBP180ABC, was purified to homogeneity by affinity chromatography.
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New Zealand White rabbits were immunized with the purified mBP180 fusion protein and the IgG fraction from the serum (designated R530) was purified as previously described. 19 The IgG fractions were concentrated, sterilized by ultrafiltration and the protein concentrations determined by OD 280 [E (1%, 1 cm) = 19 The pathogenicity of these IgG preparations was tested by passive transfer experiments as described below.
Induction of experimental BP and clinical evaluation of animals:
Neonates were given on the back one i.d. injection of a sterile solution of IgG in PBS (50 μl IgG, 2.64 mg IgG/g body weight) as described elsewhere. 19 The skin at the IgG-injection site of the mice from the test and control groups was examined at different time points after the IgG injection. The extent of cutaneous disease was scored as follows: "(-)", no detectable skin disease; "1+", mild erythematous reaction with no evidence of the epidermal detachment sign [this sign was elicited by gentle friction of the mouse skin which, when positive, produced fine, persistent wrinkling of the epidermis]; "2+", intense erythema and epidermal detachment sign involving 10-50% of the epidermis in localized areas; and "3+", intense erythema with frank epidermal detachment sign involving more than 50% of the epidermis in the injection site.
After clinical examination, the animals were sacrificed, and skin and serum specimens were obtained. Skin sections were used for routine histological examination by light microscopy (H/E staining) to localize the lesional site and neutrophil infiltration and toluidine blue staining to quantify mast cells and mast cell degranulation. Direct IF of skin sections were performed to detect rabbit IgG and mouse C3 deposition at the BMZ. Skin protein extracts were analyzed by myeloperoxidase (MPO) enzymatic assay to quantify the neutrophil accumulation at the skin 
PMN isolation:
Mouse PMN were isolated from heparinized blood by dextran sedimentation followed by separation on a density gradient as described. 36 Red blood cells were removed from the cell preparation by hypotonic lysis in 0.2% NaCl. PMN were washed and resuspended in cold PBS/10 mM glucose, counted in a hemocytometer, and adjusted to a concentration of 1x10 7 cells/ml. PMN purity of the final cell preparation was consistently >96% as determined by cellcytospin and LeukoStat staining (Fisher Diagnostics). The viability of the neutrophils was >96%
as determined by trypan blue exclusion.
Quantification of NE and MMP-9 in vitro and in vivo:
To quantify neutrophil activation in vitro, purified neutrophils from WT or Mac-1 KO mice were incubated with purified rabbit antimBP180 IgG in the presence of purified mBP180 antigen at 37 0 C for 30 min. 37 Neutrophil elastase (NE) and MMP-9 in the supernatant were quantified by NE activity assay and MMP-9 colorimetric assay.
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NE activity was measured using the NE-specific substrate
Systems Products) as described previously. 24 The NE activity was expressed as relative NE To quantify infiltrating neutrophil activation at the IgG-injection site, 100 :l of PBS was injected into the skin of WT and Mac-1 KO mice at 4 and 24 h after pathogenic IgG injection and withdrawn 1 min later. The "washout" PBS was centrifuged at low speed (1,000 g) for 5min
to remove cells and then high speed (12,000 g) for 5 min to remove cell debris. 24 The supernatant was analyzed by MMP-9 and NE enzyme assays as given above.
Intradermal injection of PMN. PMN were purified from WT and Mac-1 KO mice. Mac-1 KO mice were injected i.d. with pathogenic anti-mBP180 IgG (2.64 mg/g body weight/50 μl PBS).
Two h later, these mice were injected with 5x10 5 PMN i.d. (in 50 μl of PBS/10 mM glucose) at the same site. 21 The animals were analyzed 24 h after the IgG injections, as described above.
Immunostaining of active caspase 3: Apoptotic neutrophils in the skin of IgG-injected mice were identified by indirect IF with antibody directed against the active form of caspase 3 as described with some modification. 38 Briefly, mouse skin biopsies were fixed in 10% PBSbuffered formalin overnight and embedded in paraffin. The cut skin sections (6 μm thick) were stained by routine H/E and total neutrophils were counted under light microscope. To quantify apoptotic neutrophils, the paraffin-embedded skin sections were deparaffinized and hydrated by series of xylene and ethanol, followed by boiling for 10 min in 10 mM sodium citrate buffer pH 6.0 for antigen unmasking. The unmasked skin sections were incubated with rabbit anti-cleaved caspase-3 monoclonal antibody at 1:100 dilution (Cell Signaling Technology, Beverly, MA) in
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Neutrophil apoptosis was expressed as relative neutrophil apoptosis (% apoptotic neutrophils/field).
Statistical analysis:
The data were expressed as mean ± SEM and were analyzed using Student's t-test. A p value less than 0.05 was considered significant. 13 and MMP-9 ( Figure 3B) . In vivo, however, extracellular levels of NE and MMP-9 released by infiltrating neutrophils in the IgG-injected skin of Mac-1 KO mice were significantly reduced as compared to the diseased WT mice at 4 and 24 h time points (Figures 3C and 3D) . These results suggest that reduced neutrophil activation in Mac-1 KO mice results in below threshold levels of MMP-9 and NE, which are responsible for the amplification of neutrophil infiltration and subsequent blistering. Immunostaining identified apoptotic neutrophils in the dermis of both WT and Mac-1 KO mice that increased over time ( Figure 6A) . Notably, the number of apoptotic neutrophils in the Mac-1 KO mice was significantly lower than the WT mice at all three timepoints tested ( Figure 6B ).
This suggests that Mac-1 deficiency results in an increase in the survival of tissue accumulated neutrophils in experimental BP. 
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attractive therapy for human autoimmune blistering diseases since there would be fewer predicted side effects on other immune functions in patients.
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